Typenex Medical Awarded Agreements for Patient Identification and Manual Microbiology with Premier, Inc.

New Agreements Expand Typenex Medical’s Offerings in the Premier Contract Portfolio

CHICAGO, July 14, 2025 /PRNewswire/ — Typenex® Medical has been awarded two new national group purchasing agreements with Premier, Inc., a leading healthcare improvement company. The contracts for Patient Identification and Manual Microbiology will take effect August 1, 2025 and September 1, 2025, respectively. These agreements will allow Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier.

As a certified diversity supplier, Typenex Medical is proud to offer dedicated one-on-one customer service and value-driven solutions across seven clinical commodity categories. “We are excited to continue expanding our offerings within the Premier portfolio,” said Craig Searls, Director of National Contracting. “This opportunity enables us to further support Premier members in minimizing spend and maximizing value from our comprehensive offerings.”

Premier Contracts at a Glance

Labels, Identification Bands and Related Products

  • National Contract #PP-NS-1614
  • NEW National Contract #PP-NS-2106 (Effective 8/1/2025)
  • 3.5% conversion rebate
  • Domestically manufactured
  • Products: Patient Identification Bands, Medical Labels

Manual Microbiology

  • National Contract #PA-LA-580
  • NEW National Contract #PP-LA-731 (Effective 9/1/2025)
  • Products: Inoculation Loops, Specimen Collection Swabs, Viral Transport Media

Fluid Waste Management Pads and Related Products

  • National Contract #PP-OR-1700          
  • AscenDrive Contract #AD-OR-2154
  • SURPASS Contract #SP-OR-2154
  • Products: Absorbent Floor Mats and Rolls, Suction Discs, Suction Mats

Histology and Cytology Products, Equipment and Services

  • National Contract #PP-LA-653
  • Products: Histology Cassettes, Microscope Slides

Respiratory Therapy Products: Respiratory Disposables

  • National Contract #PP-NS-1743
  • 3.5% conversion rebate
  • Products: Breathing Circuits, Filters, HMEs, Other Respiratory Disposables

“The addition of these two agreements reflects our company mission to enhance patient care while supporting cost-efficiency for providers,” added Searls. “We are grateful for the continued trust that Premier and its members place in us and we remain committed to delivering smart solutions that help improve outcomes and streamline operations.” Typenex Medical will also be attending Premier’s Breakthroughs this July 15–17, where members can connect with the team and learn more about the latest products on contract.

Premier is a leading technology-driven healthcare improvement company, providing solutions to two-thirds of all healthcare providers in the U.S. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers, payers and policymakers to make healthcare better with national scale, smarter with actionable intelligence and faster with novel technologies. With integrated data and analytics, collaboratives, supply chain solutions, consulting and other services, Premier enables better care and outcomes at a lower cost.

About Typenex® Medical, LLC

Typenex® Medical is a medical device and supply company founded by entrepreneur and investor, John Fife. Typenex Medical is committed to connecting with customers to understand their process needs, then delivering tailored products to help streamline workflows. For more information, please visit www.typenex.com.

Contact: Craig Searls
Director, National Contracting and Corporate Accounts
866-897-3639
sales@typenex.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/typenex-medical-awarded-agreements-for-patient-identification-and-manual-microbiology-with-premier-inc-302503584.html

SOURCE Typenex® Medical, LLC

Staff

Recent Posts

What Is the Best GLP-1 Supplement for Weight Loss? Industry Analysis Reveals Probiotic Akkermansia Formulas as Affordable Ozempic Alternatives

Health Journey Addresses 'Best GLP-1 Supplement' Question with Akkermansia-Based Formula Analysis as Six-Month Costs Compare…

10 hours ago

After Trump’s Marijuana Executive Order, Will the DEA Face a Court Imposed Deadline from MMJ’s Writ of Mandamus?

After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts?"Despite…

1 day ago

Black Book Research Releases Its 2026 Annual Methodology and Governance Statement for Healthcare IT Vendor Rankings

Boards and executive buyers are raising the 2026 bar for all product and service rankings…

1 day ago

Black Book Research Releases Its 2026 Annual Methodology and Governance Statement for Healthcare IT Vendor Rankings

Boards and executive buyers are raising the 2026 bar for all product and service rankings…

1 day ago

Awake Breast Augmentation: Gruber Plastic Surgery Highlights Live Implant Sizing Under Local Anesthesia With No Sedation for Eligible Patients

Tampa based Celebrity Board-Certified Plastic Surgeon Dr. Meegan Gruber expands an interactive approach that allows…

1 day ago